# Kyntra Bio (KYNB) — Overview

KYNB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/kynb

## Price

Last close $5.36 on Oct 15, 2026. 52-week range $5.36 – $11.18.

## Company profile

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $4.6M |
| Revenue (quarter) | −$1.5M |
| Revenue growth (year over year) | -209.35% |
| Gross profit (trailing twelve months) | $289,000.00 |
| Gross margin | 6.26% |
| Net income (trailing twelve months) | $183.2M |
| Net income (quarter) | $12.0M |
| Net income growth (year over year) | 257.49% |
| Net margin | 3968.63% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | $45.30 |
| Book value per share | −$7.44 |
| P/E (trailing twelve months) | 0.1 |
| Price to book | — |
| Debt to assets | 108.06% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Kyntra Bio (KYNB) profitable?

Yes. Kyntra Bio earned $183.2M in net income over the trailing twelve months, a net margin of 3968.63%.

### How much revenue does Kyntra Bio (KYNB) make?

Kyntra Bio generated $4.6M in revenue over the trailing twelve months, down 209.35% year over year.

### What is KYNB's P/E ratio?

Kyntra Bio trades at 0.1 times trailing twelve-month earnings, on an EPS of $45.30.

### How do I buy stock in Kyntra Bio (KYNB)?

KYNB trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).